Clinical Trials Directory

Trials / Recruiting

RecruitingNCT05455593

Effectiveness of the Combination of Water Aerobics and Metacognitive Training

Efficacy of the Combination of Water Aerobics and Metacognitive Training (MCT) on Psychological and Physical Health Variables and Their Relationship With SP1 and SP4 Biomarkers in People With Psychosis

Status
Recruiting
Phase
N/A
Study type
Interventional
Enrollment
50 (estimated)
Sponsor
Fundació Sant Joan de Déu · Academic / Other
Sex
All
Age
18 Years – 55 Years
Healthy volunteers
Not accepted

Summary

The objective of this study is to assess the efficacy of a combined intervention of water aerobics and Metacognitive Training (MCT), compared to each intervention separately, in people with psychosis. One purpose is to analyze the improvement of clinical, cognitive, metacognitive and psychosocial variables, motor coordination and physical health condition. Another purpose is to study the changes in SP1 and SP4 biomarker transcription levels as a function of the intervention received. The hypothesis is that the combined intervention will enhance the benefits of each intervention separately, specifically in symptoms, cognition, metacognition and psychosocial variables.

Conditions

Interventions

TypeNameDescription
BEHAVIORALWater aerobics1-hour session of water aerobics per week, for 3 months. A specialized trainer will carry out water aerobics sessions and will focus on motor coordination, strength and cardiovascular workout.
BEHAVIORALMetacognitive Training (MCT)1-hour session of MCT per week, for 3 months. A trained psychologist will carry out the MCT sessions. MCT addresses the most common cognitive biases in psychosis. Each session will focus on one topic, such as attributional style, jumping to conclusions, theory of mind, emotion recognition, memory or empathy.
BEHAVIORALCombined interventionPatients in this arm will participate in both in water aerobics and MCT sessions, once a week for each intervention.

Timeline

Start date
2021-08-02
Primary completion
2026-06-01
Completion
2026-06-01
First posted
2022-07-13
Last updated
2024-08-22

Locations

1 site across 1 country: Spain

Source: ClinicalTrials.gov record NCT05455593. Inclusion in this directory is not an endorsement.